XPhyto Therapeutics Corp. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CAD 3,698 compared to CAD 260,515 a year ago. Operating loss was CAD 5.204 million compared to CAD 3.669 million a year ago. Net loss was CAD 5.366 million compared to CAD 3.687 million a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.07 a year ago.